Work

Figure S5 from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Year: 2023

Type: other

Abstract: Overexpression of secreted IL-33 in B16 tumors increased effector function of the tumor infiltrating T cells.

DOI: 10.1158/2326-6066.22543723

Authors: Lujun Chen, Runzi Sun, Junchi Xu, Wensi Zhai, Dachuan Zhang, Min Yang, Cuihua Yue, Yichao Chen, Song Li, Heth Turnquist, Jingting Jiang, Binfeng Lu

Language: English

Topic: IL-33, ST2, and ILC Pathways

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362629702

Cites:

Cited by:

Related to: 10